Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. REGN has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
REGN stock price ended at $602.64 on , after rising0.48%
The Regeneron Pharmaceuticals Inc stock price increased by 0.48% on the last trading day (), rising from 598.33 to 602.64. Throughout the last trading session, the stock experienced a fluctuation of 2.90% , ranging from a day low of $585.78 to a day high of 602.79. The price has declined in 3 of the last 10 days, resulting in a total change of 10.29% during this period. On the last day, trading volume decrease by -352.84K shares, with the rising prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 964.39K shares were traded, amounting to approximately 575.45M.
REGN Technical Signals
REGN(Regeneron Pharmaceuticals Inc Corp) has buy signals and sell signals now. The average turnover of REGN over the last 5 trading days is NaN. Overall, the technical indicator signals lean more toward a outlook in the mid-term.
REGN Moving Average Analysis
Regeneron Pharmaceuticals Inc's overall moving average trend leans more bullish as of Sunday, April 27, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $, and $. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $, and $. A break-down below any of these levels will issue sell signals.
REGN Short Selling Analysis
The short sale ratio of Regeneron Pharmaceuticals Inc(REGN) as of is %, dropping from last trading day. With decreasing price from to .
Technical Signal
Technical Signals Summary
Sell
Buy
Moving Average
Swing
Negative
Stock Price Below SMA_5
Short Term
Negative
SMA_5 Below SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Negative
SMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
Bullish Signals
0 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
No Data
Bearish Signals
0 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
No Data
REGN
Name
Similarity
Up/Down
No Data
REGN Seasonality Analysis
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Regeneron Pharmaceuticals Inc (REGN.O) stock in has the highest probability of a positive return (%), while has the lowest probability (%).
Performance Seasonality
The chart shows Regeneron Pharmaceuticals Inc. (REGN)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
FAQ
Should I buy Regeneron Pharmaceuticals Inc (REGN.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. REGN has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Regeneron Pharmaceuticals Inc (REGN.O) stock in a year?
The radar chart shows that buying Regeneron Pharmaceuticals Inc (REGN.O) stock in has the highest probability of a positive return (45.45%), while has the lowest probability (45.45%).
How has Regeneron Pharmaceuticals Inc. (REGN)'s stock price performed over the past three years?
REGN's stock price fell by in Invalid Date,in by
Which bull technical signals does REGN have?
Bullish technical signals of REGN include:
Which bearish technical signals does REGN have?
Bearish technical signals of REGN include:
Is REGN a buy based on overall technical signals summary?
REGN has 2 buy signals and 5 sell signals now. Overall the technical rating for REGN is . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of REGN.
What is the trend of Regeneron Pharmaceuticals Inc (REGN)'s moving average?
Regeneron Pharmaceuticals Inc's overall moving average trend leans more bullish as of April 27 2025, with 2 negative signals and 2 positive signal.
What is price prediction for REGN stock next month?
The price prediction chart for Regeneron Pharmaceuticals Inc (REGN.O) stock, as of Invalid Date, forecasts a % change over the next month, based on its high correlation with stock patterns. The similarity between their price movements over the analyzed periods is %. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for REGN Stock?
### **Price Prediction for REGN Stock in 2025**
Based on current trends and analyst expectations, REGN stock is predicted to reach **$580 to $620** by the end of 2025. This forecast considers the stock's current price of **$564.96**, recent analyst upgrades, and positive developments such as FDA approvals for key products like Dupixent and Eylea HD. Analysts like Goldman Sachs and JP Morgan have set higher price targets, driven by confidence in REGN's pipeline and revenue growth from its collaborations with Sanofi.
What is price prediction 2030 for REGN Stock?
### **Price Prediction for REGN Stock by 2030**
Based on current trends and developments, REGN stock is predicted to reach **$950 per share** by 2030. This projection is supported by the company's strong pipeline, including the expansion of Dupixent and potential success of Eylea HD. However, risks such as increased competition and legal challenges may limit upside, capping the price below **$1000**.